These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36447832)

  • 41. Compound heterozygosity for a whole gene deletion and p.R124C mutation in CYP21A2 causing nonclassic congenital adrenal hyperplasia.
    Nasir H; Ali SI; Haque N; Grebe SK; Kirmani S
    Ann Pediatr Endocrinol Metab; 2018 Sep; 23(3):158-161. PubMed ID: 30286573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
    Kawashima Y; Usui T; Fujimoto M; Miyahara N; Nishimura R; Hanaki K; Kanzaki S
    Endocr J; 2015; 62(1):101-6. PubMed ID: 25319875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel missense mutations, GCC [Ala306]- > GTC [Val] and ACG [Thr318]- > CCG [Pro], in the CYP11B1 gene cause steroid 11beta-hydroxylase deficiency in the Chinese.
    Lee HH; Won GS; Chao HT; Lee YJ; Chung BC
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):418-22. PubMed ID: 15807871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two rare forms of congenital adrenal hyperplasia, 11β hydroxylase deficiency and 17-hydroxylase/17,20-lyase deficiency, presenting with novel mutations.
    Bulsari K; Maple-Brown L; Falhammar H
    Hormones (Athens); 2018 Mar; 17(1):127-132. PubMed ID: 29858860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adeno-Associated Virus-Mediated Gene Therapy for Patients' Fibroblasts, Induced Pluripotent Stem Cells, and a Mouse Model of Congenital Adrenal Hyperplasia.
    Naiki Y; Miyado M; Shindo M; Horikawa R; Hasegawa Y; Katsumata N; Takada S; Akutsu H; Onodera M; Fukami M
    Hum Gene Ther; 2022 Aug; 33(15-16):801-809. PubMed ID: 35838129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia.
    Schernthaner-Reiter MH; Baumgartner-Parzer S; Egarter HC; Krebs M; Kautzky-Willer A; Kirchheiner K; Luger A; Bayerle-Eder M
    J Sex Med; 2019 Oct; 16(10):1529-1540. PubMed ID: 31447379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steroid 11-beta-hydroxylase deficiency caused by compound heterozygosity for a novel mutation, p.G314R, in one CYP11B1 allele, and a chimeric CYP11B2/CYP11B1 in the other allele.
    Kuribayashi I; Nomoto S; Massa G; Oostdijk W; Wit JM; Wolffenbuttel BH; Shizuta Y; Honke K
    Horm Res; 2005; 63(6):284-93. PubMed ID: 16024935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metformin-responsive classic salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report.
    Mapas-Dimaya AC; Agdere L; Bahtiyar G; Mejia JO; Sacerdote AS
    Endocr Pract; 2008 Oct; 14(7):889-91. PubMed ID: 18996819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishment of Clinical and Lab Algorithms for the Identification of Carriers of Mutations in CYP21A2 - A Study of 365 Children and Adolescents.
    Meinel J; Haverkamp T; Wünsche F; Richter-Unruh A
    Exp Clin Endocrinol Diabetes; 2021 Jul; 129(7):492-499. PubMed ID: 32838438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The combination of a novel 2 bp deletion mutation and p.D63H in CYP11B1 cause congenital adrenal hyperplasia due to steroid 11β-hydroxylase deficiency.
    Long Y; Han S; Zhang X; Zhang X; Chen T; Gao Y; Tian H
    Endocr J; 2016; 63(3):301-10. PubMed ID: 26806323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
    Castro PS; Rassi TO; Araujo RF; Pezzuti IL; Rodrigues AS; Bachega TASS; Silva IN
    J Pediatr Endocrinol Metab; 2019 May; 32(5):499-504. PubMed ID: 31028712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disorders of the aldosterone synthase and steroid 11beta-hydroxylase deficiencies.
    Peter M; Dubuis JM; Sippell WG
    Horm Res; 1999; 51(5):211-22. PubMed ID: 10559665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.
    Krone N; Rose IT; Willis DS; Hodson J; Wild SH; Doherty EJ; Hahner S; Parajes S; Stimson RH; Han TS; Carroll PV; Conway GS; Walker BR; MacDonald F; Ross RJ; Arlt W;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E346-54. PubMed ID: 23337727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency.
    Peter M
    Semin Reprod Med; 2002 Aug; 20(3):249-54. PubMed ID: 12428205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CYP21A2 p.E238 deletion as result of multiple microconversion events: a genetic study on an Italian congenital adrenal hyperplasia (CAH) family.
    Concolino P; Mello E; Zuppi C; Toscano V; Capoluongo E
    Diagn Mol Pathol; 2013 Mar; 22(1):48-51. PubMed ID: 23370425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Greek girl with 11β-hydroxylase deficiency due to compound heterozygosity for two novel mutations in CYP11B1 gene.
    Marakaki C; Papadopoulou A; Karapanou O; Papadimitriou DT; Kleanthous K; Papadimitriou A
    Endocrinol Diabetes Metab Case Rep; 2015; 2015():150074. PubMed ID: 26525354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comprehensive Analysis of Congenital Adrenal Hyperplasia Using Long-Read Sequencing.
    Liu Y; Chen M; Liu J; Mao A; Teng Y; Yan H; Zhu H; Li Z; Liang D; Wu L
    Clin Chem; 2022 Jul; 68(7):927-939. PubMed ID: 35714169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.
    Guarnotta V; Niceta M; Bono M; Marchese S; Fabiano C; Indelicato S; Di Gaudio F; Garofalo P; Giordano C
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105554. PubMed ID: 31805392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CONGENITAL ADRENAL HYPERPLASIA WITH COMPOUND HETEROZYGOUS I2 SPLICE AND P453S MUTATIONS.
    Almacan B; Ozdemir N; Onay H; Hekimsoy Z
    Acta Endocrinol (Buchar); 2022; 18(2):228-231. PubMed ID: 36212252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.